Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study record history now shows a new version (v3.6.6) replacing the previous v3.6.5, indicating an administrative update to the page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedA new revision entry v3.6.5 has been added to the study record history, and the previous revision v3.6.4 has been removed.SummaryDifference0.1%

- Check54 days agoChange DetectedA new record-history entry for v3.6.4 is added, and the previous entry v3.6.3 is removed, representing an additional revision to the study record.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, signaling an update to the record documentation. This reflects administrative maintenance rather than changes to core study content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe record history shows a new revision tag v3.6.2 replacing the previous v3.6.0, signaling an update to the study record history.SummaryDifference0.1%

- Check97 days agoChange DetectedThe record history now shows recruitment is closed ('No longer looking for participants'), indicating enrollment has ended. The revision tag has been updated to v3.6.0, replacing the old v3.5.5.SummaryDifference0.7%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.